V. Holloway

480 total citations
9 papers, 387 citations indexed

About

V. Holloway is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, V. Holloway has authored 9 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in V. Holloway's work include Alzheimer's disease research and treatments (4 papers), Wound Healing and Treatments (3 papers) and Prion Diseases and Protein Misfolding (2 papers). V. Holloway is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Wound Healing and Treatments (3 papers) and Prion Diseases and Protein Misfolding (2 papers). V. Holloway collaborates with scholars based in United States, United Kingdom and New Zealand. V. Holloway's co-authors include Todd E. Golde, Lisa Smithson, Pritam Das, Yona Levites, Karen Jansen, Rachel Dakin, M. Paul Murphy, Michelle M. Nicolle, Thomas Kukar and Jason L. Eriksen and has published in prestigious journals such as Journal of Neuroscience, PEDIATRICS and Critical Care Medicine.

In The Last Decade

V. Holloway

9 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Holloway United States	7	171	127	108	76	57	9	387
Diane M. Lang United States	7	324 1.9×	251 2.0×	112 1.0×	54 0.7×	58 1.0×	8	562
Javier Pacheco‐Quinto United States	11	222 1.3×	137 1.1×	84 0.8×	78 1.0×	50 0.9×	13	489
G Mehlhorn Germany	8	234 1.4×	131 1.0×	87 0.8×	119 1.6×	42 0.7×	23	437
Eiichi Oguni Japan	8	191 1.1×	120 0.9×	42 0.4×	76 1.0×	25 0.4×	13	404
Tao Shen China	8	235 1.4×	226 1.8×	120 1.1×	99 1.3×	58 1.0×	17	576
Sara Sarroca Spain	9	196 1.1×	139 1.1×	66 0.6×	94 1.2×	38 0.7×	11	409
Dominique Drouin France	12	180 1.1×	224 1.8×	57 0.5×	34 0.4×	116 2.0×	17	605
James L. Buescher United States	11	379 2.2×	223 1.8×	112 1.0×	287 3.8×	44 0.8×	14	709
Maya L. Gosztyla United States	7	278 1.6×	234 1.8×	53 0.5×	95 1.3×	76 1.3×	10	515
Angela Holly Villamagna United States	5	183 1.1×	56 0.4×	65 0.6×	64 0.8×	30 0.5×	9	379

Countries citing papers authored by V. Holloway

Since Specialization

Citations

This map shows the geographic impact of V. Holloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Holloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Holloway more than expected).

Fields of papers citing papers by V. Holloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Holloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Holloway. The network helps show where V. Holloway may publish in the future.

Co-authorship network of co-authors of V. Holloway

This figure shows the co-authorship network connecting the top 25 collaborators of V. Holloway. A scholar is included among the top collaborators of V. Holloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Holloway. V. Holloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kukar, Thomas, Jason L. Eriksen, V. Holloway, et al.. (2007). Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neuroscience. 8(1). 54–54. 102 indexed citations

Lawlor, P., Ross Bland, Pritam Das, et al.. (2007). Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels. Molecular Neurodegeneration. 2(1). 11–11. 54 indexed citations

Levites, Yona, Karen Jansen, Lisa Smithson, et al.. (2006). Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice. Journal of Neuroscience. 26(46). 11923–11928. 103 indexed citations

Das, Pritam, Lisa Smithson, Robert Price, et al.. (2006). Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.. Journal of Neuroinflammation. 3(1). 17–17. 9 indexed citations

Gotō, Masakatsu, Thyyar M. Ravindranath, Nadeem Fazal, et al.. (2004). Exacerbation of intestinal permeability in rats after a two-hit injury: Burn and Enterococcus faecalis infection*. Critical Care Medicine. 32(11). 2267–2273. 35 indexed citations

Carroll, Camille, V. Holloway, Jonathan M. Brotchie, & Ian Mitchell. (1995). Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: Functional implications for treatment of parkinsonian symptoms. Psychopharmacology. 119(1). 55–65. 44 indexed citations

Hess, John L., V. Holloway, & J. Dankert. (1983). Incidence of Postextraction Bacteremia Under Penicillin Cover in Children with Cardiac Disease. PEDIATRICS. 71(4). 554–558. 34 indexed citations

Holt, P.J., et al.. (1970). The Effect of a Fibrinolytic Agent (Arvin) on Wound Healing and Collagen Formation. Clinical Science. 38(2). 9P–9P. 2 indexed citations

Holt, P.J., et al.. (1970). Effect of a fibrinolytic agent (Arvin) on wound healing and collagen formation.. Annals of the Rheumatic Diseases. 29(3). 335–336. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact